Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 68,200 shares at $41.35 ($2.8M) on 2007-01-03, disclosed to the SEC on 2007-01-05.
Scheduled sale ($2.8M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.89 | 500 | $20K | 0.7% |
| 2 | $40.90 | 200 | $8K | 0.3% |
| 3 | $41.00 | 24,974 | $1.0M | 36.4% |
| 4 | $41.03 | 5,000 | $205K | 7.3% |
| 5 | $41.15 | 1,204 | $50K | 1.8% |
| 6 | $41.21 | 1,400 |
| $58K |
| 2.1% |
| 7 | $41.22 | 700 | $29K | 1.0% |
| 8 | $41.23 | 100 | $4K | 0.1% |
| 9 | $41.25 | 300 | $12K | 0.4% |
| 10 | $41.30 | 4,951 | $204K | 7.3% |
| 11 | $41.35 | 8,342 | $345K | 12.3% |
| 12 | $41.36 | 3,800 | $157K | 5.6% |
| 13 | $41.40 | 1,800 | $75K | 2.7% |
| 14 | $41.41 | 800 | $33K | 1.2% |
| 15 | $41.42 | 5,000 | $207K | 7.4% |
| 16 | $41.43 | 29 | $1K | 0.0% |
| 17 | $41.50 | 5,400 | $224K | 8.0% |
| 18 | $41.51 | 639 | $27K | 0.9% |
| 19 | $41.52 | 671 | $28K | 1.0% |
| 20 | $41.53 | 200 | $8K | 0.3% |
| 21 | $41.54 | 200 | $8K | 0.3% |
| 22 | $41.55 | 200 | $8K | 0.3% |
| 23 | $41.58 | 100 | $4K | 0.1% |
| 24 | $41.59 | 190 | $8K | 0.3% |
| 25 | $41.60 | 100 | $4K | 0.1% |
| 26 | $41.66 | 1,200 | $50K | 1.8% |
| 27 | $41.67 | 100 | $4K | 0.1% |
| 28 | $41.68 | 100 | $4K | 0.1% |
| Total | $41.21 avg | 68,200 | $2.8M | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |